GA NCORP

TRIALS & PROVIDERS

Menu

NCORP Trials

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

Status
Completed
Cancer Type
Breast Cancer
Colon/Rectal Cancer
Gynecologic Cancers
Head and Neck Cancer
Kidney Cancer
Liver Cancer / Hepatoblastoma
Lung Cancer
Melanoma
Ovarian Cancer
Primary Peritoneal Cancer
Solid Tumor
Stomach/ Gastric Cancer
Unknown Primary
Trial Phase
Phase I
Phase II
Eligibility
18 Years and older, Male and Female
Study Type
Treatment
NCD ID
NCT02178722
Protocol IDs
INCB 24360-202 (primary)
NCI-2015-01316
Study Sponsor
Incyte Corporation
NCI Full Details
http://clinicaltrials.gov/show/NCT02178722

Summary

The purpose of this study was to assess the safety, tolerability, and efficacy when combining
MK-3475 and INCB024360 in participants with certain cancers. This study was conducted in 2
phases, Phase 1 and Phase 2.
CALL EMAIL

Copyright © 2015, Georgia NCI Community Oncology Research Program. All Rights Reserved.
Powered by GeorgiaCancerInfo.org
Website Design & Development by Peachtree Solutions.